New synthetic molecules could transform cannabis treatment
Pharma companies can’t make reliable, consistent drugs from cannabis plant compounds. EPM’s synthetic cannabis acid molecules could make it possible.
Pharma companies can’t make reliable, consistent drugs from cannabis plant compounds. EPM’s synthetic cannabis acid molecules could make it possible.
Former Teva Israel CEO is leading InnoCan in formulating topical treatments combining proven drugs with cannabis compounds CBD and hemp oil.
Lead Israeli researcher seeks a partner for further research, and investigates how the new pre-clinical trials approach could heal other autoimmune diseases.